Bone pain palliation with strontium-89 in cancer patients with bone metastases

Quarterly Journal of Nuclear Medicine

Volumn 45, Issue 1, 2001, Pages 78-83

  Giammarile, F ^a   Mognetti, T ^a   Resche, I ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

Bone neoplasms, radiotherapy; Bone neoplasms, secondary; Pain, therapy; Radiopharmaceuticals; Strontium radioisotopes, therapeutic use

Indexed keywords

STRONTIUM 89;

BONE DEVELOPMENT; BONE LESION; BONE MARROW DEPRESSION; BONE METASTASIS; BONE PAIN; BONE TURNOVER; CANCER PALLIATIVE THERAPY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE RESISTANCE; DOSE RESPONSE; DRUG ABSORPTION; DRUG COST; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RETENTION; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; DRUG UPTAKE; FEASIBILITY STUDY; HEALTH CARE COST; HEMODYNAMIC MONITORING; HUMAN; LEUKOCYTE COUNT; OSTEOBLAST; RADIATION PROTECTION; RADIOACTIVITY; RADIOISOTOPE THERAPY; REVIEW; THROMBOCYTE COUNT; TREATMENT OUTCOME;

BONE NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; PAIN, INTRACTABLE; PALLIATIVE CARE; STRONTIUM RADIOISOTOPES;

EID: 0034960432     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Elementary Scots. The discovery of Strontium
2. Biological investigations with radioactive calcium and strontium
3. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma
4. Strontium 89 therapy for the palliation of pain due to osseous metastases
5. Strontium-89 chloride for pain palliation in prostatic skeletal malignancy
6. Strontium-89 therapy: Measurement of absorbed dose to skeletal metastases
7. 89Sr radionuclide therapy: Dosimetry and haematological toxicity in two patients with metastasising prostatic carcinoma
8. Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate
9. Gamma camera imaging of osseous metastatic lesions by strontium-89 bremsstrahling
10. 85Sr therapy
11. Strontium-89 therapy: Strontium kinetics and dosimetry in two patients treated for metastasising osteosarcoma
12. A new look at radionuclides therapy in metastatic disease of bone
13. Use of radionuclides for the palliation of bone metastases. Review
14. The use of strontium-89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancer
15. Strontium-89 therapy for the pain of osseous metastases
16. Results in strontium-89 therapy in patients with carcinoma of prostate and incurable pain from incurable pain from metastases: A preliminary report
17. Palliation of multiple bony metastases from prostatic carcinoma with strontium-89
18. 89Sr therapy: Strontium plasma clearance in disseminated prostatic carcinoma
19. Strontium-89: Treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone
20. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer
21. Platinum compounds as radiosensitizers in strontium-89 metabolic radiotherapy
22. Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89
23. Strontium-89 and low-dose infusion cisplatin for patients with hormone refractory prostate carcinoma metastatic to bone: A preliminary report
24. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer
25. Strontium-89 chloride in the treatment of bone metastases from breast cancer
26. Acute myelogenous leukemia after exposure to strontium-89 for the treatment of adenocarcinoma of the prostate
27. Secondary leukemia: Twice is a coincidence?
28. 89Sr-chloride) in patients with prostate cancer metastatic to bone
29. Metastatic prostate cancer: Quality of life and cost considerations
30. An evaluation of the safety and efficacy of treatment with strontium-89 in patients who have previously received wide field radiotherapy
31. Removal of strontium by the chelating agent acetylaminopropylene diphosphonic acid in rats
32. Strontium-89 for symptomatic metastatic prostate cancer to bone: Recommendations for hospice patients
33. The effect of repeated strontium-89 chloride therapy on bone pain palliation in patients with skeletal cancer metastases
34. Autopsy of a cadaver containing strontium-89-chloride